USPTO serial 79430818
BIOSOMICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BLAZICH, JOAN MICHELE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with BIOSOMICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products being preparations for analysis in laboratories, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; diagnostic preparations and reagents, other than for medical or veterinary use; chemical products, namely, diagnostic preparations for diagnostic scientific purposes; chemical reagents for clinical diagnosis, except for medical or veterinary use; diagnostic kits comprising immunoassay reagents, antibodies, calibrators and assay controls for scientific use, and sample collection tubes, microplates and assay cartridges for analyzing selected bacteria; chemical products for use in immunoassay testing being immunoassay reagents, antibodies and assay controls, other than for medical or veterinary use; immunoassay reagents, other than for medical and veterinary use | ACTIVE | — |
| 005 | Preparations for medical use, namely, pharmaceutical preparations for treating skin disorders; biological preparations for use in cell cultures for medical use; chemical preparations for medical use, namely, diagnostic reagents for medical use for the detection, diagnosis, prognosis and monitoring of neurodegenerative diseases, oncological diseases and other medical conditions, diagnostic biomarker reagents for medical purposes, immunoassay reagents for medical diagnostics, and reagents for the analysis of extracellular vesicles and biological samples for medical diagnostic purposes; chemico-pharmaceutical preparations for the treatment and detection of cancer and neurodegenerative disorders; diagnostic preparations for medical use; chemical reagents for medical or veterinary use; diagnostic reagents for medical use; reagents for clinical diagnosis, namely, clinical medical reagents; reagents for clinical analyses for medical use; reagents with biomarkers for medical diagnostics; immunoassay reagents for medical use; diagnostic testing materials for medical use, namely, diagnostic test reagents for medical use | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, in vitro diagnostic devices for the screening, detection, evolution and treatment response of diseases based on the analysis of biomarkers in neuron-derived extracellular vesicles; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for testing in vitro diagnostic devices for the screening, detection, evolution and treatment response monitoring of cancer and neurodegenerative diseases based on the analysis of biomarkers in cancer-derived and neuron-derived extracellular vesicles; detector apparatus for medical use in diagnosis, namely, medical diagnostic apparatus for testing in vitro diagnostic devices used for the screening, detection, evolution and treatment response monitoring of cancer and neurodegenerative diseases based in the analysis of biomarkers in cancer-derived extracellular vesicles; apparatus for diagnostic testing for medical purposes, namely, for the detection of cancer and neurodegenerative diseases; medical diagnostic, examination and monitoring equipment, namely, medical equipment for diagnosis, examination and monitoring in the nature of respiratory equipment and monitors for medical and clinical uses; tools for medical diagnosis, namely, medical devices and surgical instruments for use in the diagnosis and surgery of the gastro-intestinal tract; medical diagnostic instruments, namely, medical diagnostic analysers, immunoassay analysers, clinical laboratory analysers, and biomarker detection analysers for the analysis of body fluids; biological sample testing instruments for medical diagnostic use; diagnostic immunoassay testing instruments for use in medical immunoassay procedures; Immunological analysis apparatus, namely, immunoassay analyzers for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LINKCARE HEALTH SERVICES, S.L.
- Other trademarks owned by LINKCARE HEALTH SERVICES, S.L.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named BIOSOMICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 4, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 4, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 30, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 29, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 15, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 15, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 1, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 17, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 17, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 17, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 1, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 18, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 18, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 8, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 7, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 4, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 25, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 25, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 21, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |